Policy and strategy Changes to prescribing antiviral and antibody treatments for COVID-19 (WHC/2025/010) New NICE advice for accessing treatments in adults at risk from severe COVID-19. Part of: Health circulars: 2024 to 2027 and Medicines and medical devices (Sub-topic) First published: 15 April 2025 Last updated: 15 April 2025 Documents Changes to prescribing antiviral and antibody treatments for COVID-19 (WHC/2025/010) Changes to prescribing antiviral and antibody treatments for COVID-19 (WHC/2025/010) , HTML HTML Related Medicines and medical devices (Sub-topic)Changes to prescribing antiviral and antibody treatments for COVID-19
